Shaobin Wei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shaobin Wei has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
Li Huang
Department of Gynaecology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
7 shared publicationsHan-Zhi Zhong
Gynaecology, Hospital of Chengdu University of Traditional Chinese Medicine
6 shared publicationsXue Liu
Department of Gynecology, Hospital of Chengdu University of Traditional Chinese Medicine
5 shared publicationsChengli Bin
Department of Gynecology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
4 shared publicationsMao-Ya Li
Gynaecology, Hospital of Chengdu University of Traditional Chinese Medicine
4 shared publicationsMaoya Li
Department of Gynecology, Hospital of Chengdu University of Traditional Chinese Medicine
4 shared publications
Latest Publications
- Open Access
- 19 October 2026
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 13, 1961915
Plant-derived nutrition and perimenopausal emotional health: current evidence and research priorities
Perimenopause combines ovarian hormone variability with changes in stress regulation, inflammatory-redox balance, neuroplasticity, and gut-brain metabolism, creating a period of increased vulnerability to depressive symptoms, anxiety, irritability, and sleep disturbance. This narrative review synthesizes evidence on plant-derived foods, bioactives, dietary supplements, and standardized botanical preparations relevant to emotional health during the menopausal transition. Targeted searches of PubMed/MEDLINE, Web of Science, and Scopus identified literature published through 31 July 2026. Evidence was classified by consumed form and reproductive-stage directness and integrated across three regulatory axes: endocrine-stress regulation, immune-redox-neuroplasticity, and gut-brain-metabolic communication. Human evidence includes small randomized trials of standardized saffron, rhapontic rhubarb, fenugreek, ashwagandha, and shatavari preparations, with product-specific psychological-symptom signals, as well as a null Hypericum-Vitex trial. Evidence for plant-rich dietary patterns and isolated bioactives derives mainly from broader menopausal or adult populations. Across studies, reproductive stage, exposure composition, symptom endpoint, and preparation standardization emerge as key determinants of interpretation. Linking symptom clusters with proposed pathway involvement generates hypotheses for prospective phenotype-stratified nutrition trials. Future studies should combine reproductive staging using the Stages of Reproductive Aging Workshop + 10 (STRAW+10) framework, prespecified emotional outcomes, dietary assessment, standardized product characterization, exposure biomarkers, metabotype profiling, and safety monitoring. This framework positions plant-derived nutrition as a testable component of perimenopausal emotional-health research and functional-food development.
- 19 October 2026
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 13, 1961915
Open AccessPlant-derived nutrition and perimenopausal emotional health: current evidence and research priorities
Perimenopause combines ovarian hormone variability with changes in stress regulation, inflammatory-redox balance, neuroplasticity, and gut-brain metabolism, creating a period of increased vulnerability to depressive symptoms, anxiety, irritability, and sleep disturbance. This narrative review synthesizes evidence on plant-derived foods, bioactives, dietary supplements, and standardized botanical preparations relevant to emotional health during the menopausal transition. Targeted searches of PubMed/MEDLINE, Web of Science, and Scopus identified literature published through 31 July 2026. Evidence was classified by consumed form and reproductive-stage directness and integrated across three regulatory axes: endocrine-stress regulation, immune-redox-neuroplasticity, and gut-brain-metabolic communication. Human evidence includes small randomized trials of standardized saffron, rhapontic rhubarb, fenugreek, ashwagandha, and shatavari preparations, with product-specific psychological-symptom signals, as well as a null Hypericum-Vitex trial. Evidence for plant-rich dietary patterns and isolated bioactives derives mainly from broader menopausal or adult populations. Across studies, reproductive stage, exposure composition, symptom endpoint, and preparation standardization emerge as key determinants of interpretation. Linking symptom clusters with proposed pathway involvement generates hypotheses for prospective phenotype-stratified nutrition trials. Future studies should combine reproductive staging using the Stages of Reproductive Aging Workshop + 10 (STRAW+10) framework, prespecified emotional outcomes, dietary assessment, standardized product characterization, exposure biomarkers, metabotype profiling, and safety monitoring. This framework positions plant-derived nutrition as a testable component of perimenopausal emotional-health research and functional-food development.
- Open Access
- 15 October 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1907483
Machine learning and deep learning for diagnosis of endometriosis: systematic review and meta-analysis
Objective: To assess the diagnostic accuracy of machine learning (ML) and deep learning (DL) models for endometriosis. Methods: A systematic review and meta-analysis were conducted in accordance with PRISMA guidelines (PROSPERO: CRD420251231469). Databases were searched through November 24, 2025. Twenty-two eligible studies were included. Risk of bias was assessed using QUADAS-2. Pooled analysis was conducted in Stata 18.0. Results: Pooled sensitivity was 0.90 (95% CI 0.86–0.93), specificity 0.75 (95% CI 0.64–0.84), and SROC-AUC 0.92 (95% CI 0.89–0.94). A positive prediction increased disease probability from 10% to 29%, whereas a negative prediction reduced it to 1%. Multicenter design and DL were associated with lower sensitivity. Results were robust. Conclusions: ML/DL models demonstrate high diagnostic performance and are promising for non-invasive auxiliary diagnosis. Large multicenter prospective studies and multimodal models are needed to enable clinical translation. Systematic Review Registration : https://www.crd.york.ac.uk/PROSPERO/view/CRD420251231469 , identifier CRD420251231469
- 15 October 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1907483
Open AccessMachine learning and deep learning for diagnosis of endometriosis: systematic review and meta-analysis
Objective: To assess the diagnostic accuracy of machine learning (ML) and deep learning (DL) models for endometriosis. Methods: A systematic review and meta-analysis were conducted in accordance with PRISMA guidelines (PROSPERO: CRD420251231469). Databases were searched through November 24, 2025. Twenty-two eligible studies were included. Risk of bias was assessed using QUADAS-2. Pooled analysis was conducted in Stata 18.0. Results: Pooled sensitivity was 0.90 (95% CI 0.86–0.93), specificity 0.75 (95% CI 0.64–0.84), and SROC-AUC 0.92 (95% CI 0.89–0.94). A positive prediction increased disease probability from 10% to 29%, whereas a negative prediction reduced it to 1%. Multicenter design and DL were associated with lower sensitivity. Results were robust. Conclusions: ML/DL models demonstrate high diagnostic performance and are promising for non-invasive auxiliary diagnosis. Large multicenter prospective studies and multimodal models are needed to enable clinical translation. Systematic Review Registration : https://www.crd.york.ac.uk/PROSPERO/view/CRD420251231469 , identifier CRD420251231469
- Open Access
- 30 April 2026
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17, 1822976
Cervical human papillomavirus: the therapeutic target of botanical drugs
Persistent cervical human papillomavirus (HPV) infection is the key biological event underlying high-grade squamous intraepithelial lesions, cervical cancer development, and recurrence risk. Botanical drugs and their bioactive metabolites have therefore attracted interest as potential adjunctive interventions, particularly because they can modulate multiple biological pathways relevant to viral persistence and clearance. This review critically synthesizes the botanical drugs and their metabolites evaluated in cervical HPV-related studies, organizing the available evidence around experimentally interpretable therapeutic outputs. The reviewed literature indicates that specific botanical drugs are associated with the suppression of HPV oncogene expression, the disruption of viral DNA maintenance, and the modulation of critical host responses. However, the current evidence remains heterogeneous and is fundamentally limited by incomplete phytochemical characterization, variable experimental model relevance, insufficient pharmacokinetic data, and an overreliance on simplified preclinical systems. Overall, current findings support the pharmacological relevance of selected botanical drugs in persistence-related cervical HPV biology, but they do not yet establish consistent clinical efficacy. Future research should prioritize standardized botanical formulations, genotype-stratified study designs, persistence-relevant biomarkers, and durable virological and lesion-related outcomes to improve translational value.
- 30 April 2026
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17, 1822976
Open AccessCervical human papillomavirus: the therapeutic target of botanical drugs
Persistent cervical human papillomavirus (HPV) infection is the key biological event underlying high-grade squamous intraepithelial lesions, cervical cancer development, and recurrence risk. Botanical drugs and their bioactive metabolites have therefore attracted interest as potential adjunctive interventions, particularly because they can modulate multiple biological pathways relevant to viral persistence and clearance. This review critically synthesizes the botanical drugs and their metabolites evaluated in cervical HPV-related studies, organizing the available evidence around experimentally interpretable therapeutic outputs. The reviewed literature indicates that specific botanical drugs are associated with the suppression of HPV oncogene expression, the disruption of viral DNA maintenance, and the modulation of critical host responses. However, the current evidence remains heterogeneous and is fundamentally limited by incomplete phytochemical characterization, variable experimental model relevance, insufficient pharmacokinetic data, and an overreliance on simplified preclinical systems. Overall, current findings support the pharmacological relevance of selected botanical drugs in persistence-related cervical HPV biology, but they do not yet establish consistent clinical efficacy. Future research should prioritize standardized botanical formulations, genotype-stratified study designs, persistence-relevant biomarkers, and durable virological and lesion-related outcomes to improve translational value.
- Top Cited PapersOpen Access
- 21 March 2026
- Published by Springer Nature in Biomarker Research
- Vol. 14
Multi-omics biomarkers in female fertility: from oocyte quality to endometrial receptivity and clinical translation
High-throughput omics technologies have transformed our understanding of female reproductive biology, revealing molecular interactions governing oocyte mat
- 21 March 2026
- Published by Springer Nature in Biomarker Research
- Vol. 14
Top Cited PapersOpen AccessMulti-omics biomarkers in female fertility: from oocyte quality to endometrial receptivity and clinical translation
High-throughput omics technologies have transformed our understanding of female reproductive biology, revealing molecular interactions governing oocyte mat
- Open Access
- 26 January 2026
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17
Ginseng and its active compounds in ovarian aging: mechanistic basis and translational prospects
Ovarian aging is characterized by follicular depletion and declining oocyte quality, encompassing both physiological age-related decline and pathological forms such as diminished ovarian reserve, premature ovarian insufficiency and premature ovarian failure. These changes are associated with long-term systemic comorbidities across the female life course, particularly in the context of estrogen deficiency. Ginseng as a botanical drug ( Panax ginseng C.A.Mey.) and its active compounds, including ginsenosides Rg1, Rb1 and Rg3, the gut–derived metabolite Compound K and ginseng polysaccharides, have emerged as multitarget candidates for delaying ovarian aging-associated functional decline and supporting reproductive health. This review integrates preclinical evidence on how ginseng-related compounds attenuate oxidative stress, preserve mitochondrial function, support energy metabolism and modulate ovarian inflammaging and the senescence-associated secretory phenotype. They also rebalance apoptosis and autophagy, thereby supporting granulosa cell survival and follicle development. We summarize their regulatory effects on hypothalamic–pituitary–ovarian axis activity and on ovarian hormone receptor expression, which may help preserve ovarian endocrine function during aging. Across mechanistic domains, the most consistent ovary-relevant evidence converges on redox control and mitochondrial integrity and function, together with dampening of NF-κB and NLRP3-linked inflammatory signaling and SASP-associated features, whereas evidence for direct hypothalamic–pituitary modulation and for durable multisystem outcome modification remains more exploratory. Preclinical studies indicate that ginseng-related compounds can influence skeletal, cardiovascular, hepatic, metabolic and neurocognitive phenotypes that accompany estrogen deficiency. However, the evidence base remains heterogeneous and largely preclinical, and causal links to long-term functional reproductive outcomes are still limited. Interpretation of the existing literature is hampered by differences in botanical sources, processing methods, formulations, dosing regimens, treatment duration and routes of administration, which complicate evaluation of in vivo exposure and pharmacodynamic response, particularly for orally administered ginsenosides that undergo microbiota-mediated biotransformation and show inter-individual pharmacokinetic variability in some studies, with consequent uncertainty in dose relevance and exposure consistency across populations. Further progress toward clinical application may be facilitated by traceable and chemically defined ginseng preparations, exposure-guided oral dosing and rigorously designed clinical trials that better define efficacy, safety, plausible drug–drug interaction considerations and long-term reproductive and systemic outcomes with stage-stratified designs and prioritized functional outcome measures.
- 26 January 2026
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17
Open AccessGinseng and its active compounds in ovarian aging: mechanistic basis and translational prospects
Ovarian aging is characterized by follicular depletion and declining oocyte quality, encompassing both physiological age-related decline and pathological forms such as diminished ovarian reserve, premature ovarian insufficiency and premature ovarian failure. These changes are associated with long-term systemic comorbidities across the female life course, particularly in the context of estrogen deficiency. Ginseng as a botanical drug ( Panax ginseng C.A.Mey.) and its active compounds, including ginsenosides Rg1, Rb1 and Rg3, the gut–derived metabolite Compound K and ginseng polysaccharides, have emerged as multitarget candidates for delaying ovarian aging-associated functional decline and supporting reproductive health. This review integrates preclinical evidence on how ginseng-related compounds attenuate oxidative stress, preserve mitochondrial function, support energy metabolism and modulate ovarian inflammaging and the senescence-associated secretory phenotype. They also rebalance apoptosis and autophagy, thereby supporting granulosa cell survival and follicle development. We summarize their regulatory effects on hypothalamic–pituitary–ovarian axis activity and on ovarian hormone receptor expression, which may help preserve ovarian endocrine function during aging. Across mechanistic domains, the most consistent ovary-relevant evidence converges on redox control and mitochondrial integrity and function, together with dampening of NF-κB and NLRP3-linked inflammatory signaling and SASP-associated features, whereas evidence for direct hypothalamic–pituitary modulation and for durable multisystem outcome modification remains more exploratory. Preclinical studies indicate that ginseng-related compounds can influence skeletal, cardiovascular, hepatic, metabolic and neurocognitive phenotypes that accompany estrogen deficiency. However, the evidence base remains heterogeneous and largely preclinical, and causal links to long-term functional reproductive outcomes are still limited. Interpretation of the existing literature is hampered by differences in botanical sources, processing methods, formulations, dosing regimens, treatment duration and routes of administration, which complicate evaluation of in vivo exposure and pharmacodynamic response, particularly for orally administered ginsenosides that undergo microbiota-mediated biotransformation and show inter-individual pharmacokinetic variability in some studies, with consequent uncertainty in dose relevance and exposure consistency across populations. Further progress toward clinical application may be facilitated by traceable and chemically defined ginseng preparations, exposure-guided oral dosing and rigorously designed clinical trials that better define efficacy, safety, plausible drug–drug interaction considerations and long-term reproductive and systemic outcomes with stage-stratified designs and prioritized functional outcome measures.
- Open Access
- 15 October 2025
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 25  (1) , 1-15
Efficacy and security of oral Chinese patent medicine combined with antibiotics in the treatment of pelvic inflammatory disease: a Bayesian network meta-analysis
Pelvic inflammatory disease (PID) is a group of female upper genital tract infectious diseases. The efficacy of combining Chinese patent medicine with antibiotics in treating this condition is well-established. Our objective is to conduct a Bayesian network meta-analysis (NMA) to compare the efficacy and security of different oral Chinese patent medicines combined with antibiotics for PID. Randomized controlled trials (RCTs) reporting oral Chinese patent medicine combined with antibiotics for PID were included by 7 databases from the inception of the databases to December 2024. The Literature that satisfied the inclusion criteria underwent screening, followed by an evaluation of the quality and risk of bias of the studies that were included, in accordance with the Cochrane 5.1 manual and RevMan 5.4. Subsequently, network meta-analysis was conducted using Stata 16.0 and R software. There were 73 RCTs included to evaluate the efficacy of 11 Chinese patent medicines combined with antibiotics. Kangfuyan Capsule (KFY) + antibiotics (SUCRA = 87.92%) showed the best efficacy in reducing the VAS (visual analogue scale) score. Jinying Capsule (JY) + antibiotics (SUCRA = 74.29%) showed the shortest time to relieve abdominal pain. Fuyanshu Capsule (FYS) + antibiotics showed the lowest recurrence rate (SUCRA = 99.18%) and were the most effective in reducing the level of C-reactive protein (SUCRA = 93.19%). Fuyankang tablet (FYK) + antibiotics (SUCRA = 91.15%) demonstrated highest security. The efficacy of Chinese patent medicine combined with antibiotics in the treatment of PID is better than that of antibiotics alone. Different Chinese patent medicines have their own advantages in improving abdominal pain symptoms, reducing recurrence rate and inflammatory factors levels. Clinically, these drugs can be objectively selected based on the results of the study.
- 15 October 2025
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 25  (1) , 1-15
Open AccessEfficacy and security of oral Chinese patent medicine combined with antibiotics in the treatment of pelvic inflammatory disease: a Bayesian network meta-analysis
Pelvic inflammatory disease (PID) is a group of female upper genital tract infectious diseases. The efficacy of combining Chinese patent medicine with antibiotics in treating this condition is well-established. Our objective is to conduct a Bayesian network meta-analysis (NMA) to compare the efficacy and security of different oral Chinese patent medicines combined with antibiotics for PID. Randomized controlled trials (RCTs) reporting oral Chinese patent medicine combined with antibiotics for PID were included by 7 databases from the inception of the databases to December 2024. The Literature that satisfied the inclusion criteria underwent screening, followed by an evaluation of the quality and risk of bias of the studies that were included, in accordance with the Cochrane 5.1 manual and RevMan 5.4. Subsequently, network meta-analysis was conducted using Stata 16.0 and R software. There were 73 RCTs included to evaluate the efficacy of 11 Chinese patent medicines combined with antibiotics. Kangfuyan Capsule (KFY) + antibiotics (SUCRA = 87.92%) showed the best efficacy in reducing the VAS (visual analogue scale) score. Jinying Capsule (JY) + antibiotics (SUCRA = 74.29%) showed the shortest time to relieve abdominal pain. Fuyanshu Capsule (FYS) + antibiotics showed the lowest recurrence rate (SUCRA = 99.18%) and were the most effective in reducing the level of C-reactive protein (SUCRA = 93.19%). Fuyankang tablet (FYK) + antibiotics (SUCRA = 91.15%) demonstrated highest security. The efficacy of Chinese patent medicine combined with antibiotics in the treatment of PID is better than that of antibiotics alone. Different Chinese patent medicines have their own advantages in improving abdominal pain symptoms, reducing recurrence rate and inflammatory factors levels. Clinically, these drugs can be objectively selected based on the results of the study.
- Open Access
- 9 October 2025
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 12, 1650347
Plant-based bioactives and oxidative stress in reproduction: anti-inflammatory and metabolic protection mechanisms
Oxidative stress plays a central role in reproductive disorders, with food bioactive compounds offering therapeutic potential through their antioxidant properties. This review examines antioxidant active ingredients from plant-based foods and their protective mechanisms in reproductive system oxidative stress management. Key phytochemicals including polyphenols (flavonoids, phenolic acids such as curcumin, resveratrol, and EGCG), carotenoids (lycopene, lutein), and organosulfur compounds demonstrate potent free radical scavenging capacity, regulate antioxidant enzyme activity, and inhibit lipid peroxidation through Nrf2 pathway activation and NF-κB inhibition. These natural food ingredients provide anti-inflammatory effects and metabolic benefits including improved insulin sensitivity and mitochondrial protection. Clinical evidence shows lycopene supplementation (4–8 mg/day) improves sperm motility and reduces DNA fragmentation in male infertility, resveratrol (150 mg/day) enhances ovarian reserve markers in female fertility, and curcumin reduces inflammatory markers (IL-8, TNF-α) in endometriosis while improving assisted reproductive outcomes. However, poor bioavailability limits therapeutic efficacy, with most compounds showing < 10% absorption. Advanced delivery technologies, including nanoencapsulation (5–30 fold enhancement), phospholipid complexation, and formulation with absorption enhancers (e.g., piperine), can substantially improve the bioavailability of these compounds for functional foods and dietary supplements. Emerging single-cell and multi-omics approaches provide powerful tools to unravel tissue-specific mechanisms, while future progress also depends on establishing uniform dosage standards and conducting rigorous safety assessments to address potential pro-oxidant effects and long-term interactions. Given that infertility affects 17.5% of adults globally, food-derived antioxidant interventions represent accessible strategies for managing reproductive disorders, supporting the development of nutraceuticals and novel foods for reproductive health protection.
- 9 October 2025
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 12, 1650347
Open AccessPlant-based bioactives and oxidative stress in reproduction: anti-inflammatory and metabolic protection mechanisms
Oxidative stress plays a central role in reproductive disorders, with food bioactive compounds offering therapeutic potential through their antioxidant properties. This review examines antioxidant active ingredients from plant-based foods and their protective mechanisms in reproductive system oxidative stress management. Key phytochemicals including polyphenols (flavonoids, phenolic acids such as curcumin, resveratrol, and EGCG), carotenoids (lycopene, lutein), and organosulfur compounds demonstrate potent free radical scavenging capacity, regulate antioxidant enzyme activity, and inhibit lipid peroxidation through Nrf2 pathway activation and NF-κB inhibition. These natural food ingredients provide anti-inflammatory effects and metabolic benefits including improved insulin sensitivity and mitochondrial protection. Clinical evidence shows lycopene supplementation (4–8 mg/day) improves sperm motility and reduces DNA fragmentation in male infertility, resveratrol (150 mg/day) enhances ovarian reserve markers in female fertility, and curcumin reduces inflammatory markers (IL-8, TNF-α) in endometriosis while improving assisted reproductive outcomes. However, poor bioavailability limits therapeutic efficacy, with most compounds showing < 10% absorption. Advanced delivery technologies, including nanoencapsulation (5–30 fold enhancement), phospholipid complexation, and formulation with absorption enhancers (e.g., piperine), can substantially improve the bioavailability of these compounds for functional foods and dietary supplements. Emerging single-cell and multi-omics approaches provide powerful tools to unravel tissue-specific mechanisms, while future progress also depends on establishing uniform dosage standards and conducting rigorous safety assessments to address potential pro-oxidant effects and long-term interactions. Given that infertility affects 17.5% of adults globally, food-derived antioxidant interventions represent accessible strategies for managing reproductive disorders, supporting the development of nutraceuticals and novel foods for reproductive health protection.
- Open Access
- 20 May 2025
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 12, 1591534
The neurobiology of plant-based therapeutics in women's reproductive health: mechanisms, efficacy, and clinical translation
This review examines the neurobiological mechanisms by which plant-derived compounds influence women's reproductive health through the neuroendocrine-reproductive axis. Gynecological disorders frequently present with neurological manifestations, including cognitive decline in perimenopause, anxiety and depression in polycystic ovary syndrome (PCOS), and central sensitization in endometriosis. Bioactive compounds from medicinal plants, including polyphenols and phytoestrogens, demonstrate therapeutic potential through their anti-inflammatory, antioxidant, and neuromodulatory properties. These multi-target compounds offer advantages over conventional single-target therapies by simultaneously regulating multiple physiological processes. The review explores applications in specific gynecological conditions and discusses the development of dietary supplements and functional foods incorporating these plant-derived ingredients. The growing market for these products presents opportunities for innovative formulations with enhanced bioavailability and personalized approaches. Future research directions include integrating neuroimaging with herbal research, improving clinical translation, and establishing regulatory frameworks for the global application of these plant-derived interventions to enhance female neuroendocrine-reproductive health.
- 20 May 2025
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 12, 1591534
Open AccessThe neurobiology of plant-based therapeutics in women's reproductive health: mechanisms, efficacy, and clinical translation
This review examines the neurobiological mechanisms by which plant-derived compounds influence women's reproductive health through the neuroendocrine-reproductive axis. Gynecological disorders frequently present with neurological manifestations, including cognitive decline in perimenopause, anxiety and depression in polycystic ovary syndrome (PCOS), and central sensitization in endometriosis. Bioactive compounds from medicinal plants, including polyphenols and phytoestrogens, demonstrate therapeutic potential through their anti-inflammatory, antioxidant, and neuromodulatory properties. These multi-target compounds offer advantages over conventional single-target therapies by simultaneously regulating multiple physiological processes. The review explores applications in specific gynecological conditions and discusses the development of dietary supplements and functional foods incorporating these plant-derived ingredients. The growing market for these products presents opportunities for innovative formulations with enhanced bioavailability and personalized approaches. Future research directions include integrating neuroimaging with herbal research, improving clinical translation, and establishing regulatory frameworks for the global application of these plant-derived interventions to enhance female neuroendocrine-reproductive health.
- 9 May 2025
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 42  (6) , 1925-1938
Effects of acupuncture-related therapies on pregnancy outcomes among women undergoing in vitro fertilization and embryo transfer: a Bayesian network meta-analysis
Background This network meta-analysis aimed to assess the efficacy of different acupuncture-related therapies in improving pregnancy outcomes among women undergoing in vitro fertilization and embryo transfer (IVF-ET). Methods Randomized controlled trials (RCTs) examining acupuncture-related therapies as adjuncts to IVF-ET were systematically searched in eight databases from inception until January 15, 2025. Dichotomous outcomes concerning efficacy were evaluated as odds risk (OR) and continuous data as mean difference (MD) and 95% credible intervals (CrI) utilizing R 4.1.2 and Stata 16.1. Results Through a comprehensive literature search, we ultimately identified 96 RCTs that involved 14,736 participants and 15 interventions in this systematic analysis. Based on the clinical pregnancy rate outcome, warm acupuncture for three menstrual cycles before oocyte retrieval (WA-TTP, OR 3.56, 95% CrI 2.05 to 6.25, low certainty, SUCRA = 89.54%), acupuncture combined with moxibustion for three menstrual cycles before oocyte retrieval (AC + M-TTP, OR 3.31, 95% CrI 1.05 to 11.77, low certainty, SUCRA = 78.70%), and acupuncture for one menstrual cycle before oocyte retrieval (AC-OTP, OR 2.69, 95% CrI 1.76 to 4.09, moderate certainty, SUCRA = 77.98%) demonstrated potential superiority compared to false acupuncture or no treatment (F/N). Significant subgroup differences between clinical pregnancy rates were observed by subgroup analysis. Conclusion Acupuncture-related therapies can potentially enhance clinical pregnancy rates among women undergoing IVF-ET, with WA-TTP, AC + M-TTP, and AC-OTP demonstrating potential superiority. AC-TTP demonstrated a greater efficacy in improving live birth rates, increasing endometrial thickness, and reducing pulsation index. Our findings emphasize that acupuncture-related therapies with a limited number of sessions before or after embryo transfer show minimal clinical benefit except auricular acupressure.
- 9 May 2025
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 42  (6) , 1925-1938
Effects of acupuncture-related therapies on pregnancy outcomes among women undergoing in vitro fertilization and embryo transfer: a Bayesian network meta-analysis
Background This network meta-analysis aimed to assess the efficacy of different acupuncture-related therapies in improving pregnancy outcomes among women undergoing in vitro fertilization and embryo transfer (IVF-ET). Methods Randomized controlled trials (RCTs) examining acupuncture-related therapies as adjuncts to IVF-ET were systematically searched in eight databases from inception until January 15, 2025. Dichotomous outcomes concerning efficacy were evaluated as odds risk (OR) and continuous data as mean difference (MD) and 95% credible intervals (CrI) utilizing R 4.1.2 and Stata 16.1. Results Through a comprehensive literature search, we ultimately identified 96 RCTs that involved 14,736 participants and 15 interventions in this systematic analysis. Based on the clinical pregnancy rate outcome, warm acupuncture for three menstrual cycles before oocyte retrieval (WA-TTP, OR 3.56, 95% CrI 2.05 to 6.25, low certainty, SUCRA = 89.54%), acupuncture combined with moxibustion for three menstrual cycles before oocyte retrieval (AC + M-TTP, OR 3.31, 95% CrI 1.05 to 11.77, low certainty, SUCRA = 78.70%), and acupuncture for one menstrual cycle before oocyte retrieval (AC-OTP, OR 2.69, 95% CrI 1.76 to 4.09, moderate certainty, SUCRA = 77.98%) demonstrated potential superiority compared to false acupuncture or no treatment (F/N). Significant subgroup differences between clinical pregnancy rates were observed by subgroup analysis. Conclusion Acupuncture-related therapies can potentially enhance clinical pregnancy rates among women undergoing IVF-ET, with WA-TTP, AC + M-TTP, and AC-OTP demonstrating potential superiority. AC-TTP demonstrated a greater efficacy in improving live birth rates, increasing endometrial thickness, and reducing pulsation index. Our findings emphasize that acupuncture-related therapies with a limited number of sessions before or after embryo transfer show minimal clinical benefit except auricular acupressure.